$CLBS News Article - Caladrius Biosciences Announc
Post# of 24
(Total Views: 186)
Posted On: 06/09/2022 1:35:51 PM
$CLBS News Article - Caladrius Biosciences Announces Merger Partner, Cend Therapeutics, has Treated First Patient in Phase 2b Trial of CEND-1 in Collaboration with Australasian Gastro-Intestinal Cancer Trials Group https://marketwirenews.com/news-releases/cala...50229.html
(0)
(0)Lisata Therapeutics Inc. (LSTA) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼